ClinicalTrials.gov
public full text
Public Domain
Microglia Activation in Schizophrenia
Patients with schizophrenia have volume loss in gray matter. This study is designed to evaluate whether their is microglia activation in schizophrenia using \[11C\](R)-PK11195 PET.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Recombinant CCL17 Shifts Microglial Phenotype and Protects Neurons from Oxygen-Glucose Deprivation/Reoxygenation (OGD/R) Injury#988098
- Evaluation of [18F] PBR06 and PET as a Marker of Inflammation in Subjects With Neurological Conditions#889597
- The Effect of Celecoxib on Neuroinflammation in MDD#840306
- Transcriptional regulation of disease-relevant microglial activation programs#485089
- Transcriptional regulation of disease-relevant microglial activation programs#226036
Record · ID 1058643
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive